Filing Details
- Accession Number:
- 0001209191-14-061020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-02 16:05:30
- Reporting Period:
- 2014-09-30
- Filing Date:
- 2014-10-02
- Accepted Time:
- 2014-10-02 16:05:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1113148 | Infinity Pharmaceuticals Inc. | INFI | Pharmaceutical Preparations (2834) | 330655706 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1239241 | B Anthony Evnin | C/O Infinity Pharmaceuticals, Inc 780 Memorial Drive Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-09-30 | 112,451 | $13.56 | 0 | No | 4 | S | Indirect | By Funds |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Funds |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 67,400 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.345 to $13.79, inclusive. The reporting person undertakes to provide to Infinity Pharmaceuticals, Inc., any security holder of Infinity Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- This disposition represents an aggregate of 89,982 shares held by Venrock Associates III, L.P. ("VA3"), 20,219 shares held by Venrock Associates, L.P. ("VA"), and 2,250 shares held by Venrock Entrepreneurs Fund III, L.P. ("VEF3"). Venrock Management III, LLC ("VM3") and VEF Management III, LLC ("VEFM3") are the sole general partners of VA3 and VEF3, respectively. Anthony B. Evnin is a general partner of VA and a member of VM3 and VEFM3.
Billionaire Hedge Funds
